AllianceBernstein
STOK icon

AllianceBernstein’s Stoke Therapeutics STOK Stock Holding History

AllianceBernstein’s Portfolio STOK Stock Details STOK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.03M Buy
62,390
+20,560
+49% +$660K ﹤0.01% 2038
2026
Q1 		$1.33M Buy
41,830
+1,200
+3% +$39.4K ﹤0.01% 2215
2025
Q4 		$1.29M Hold
40,630
– – ﹤0.01% 2226
2025
Q3 		$955K Hold
40,630
– – ﹤0.01% 2372
2025
Q2 		$461K Hold
40,630
– – ﹤0.01% 2688
2025
Q1 		$270K Hold
40,630
– – ﹤0.01% 2826
2024
Q4 		$448K Hold
40,630
– – ﹤0.01% 2686
2024
Q3 		$499K Hold
40,630
– – ﹤0.01% 2665
2024
Q2 		$549K Buy
40,630
+3,290
+9% +$44.4K ﹤0.01% 2623
2024
Q1 		$504K Hold
37,340
– – ﹤0.01% 2585
2023
Q4 		$196K Sell
37,340
-3,980
-10% -$17K ﹤0.01% 2984
2023
Q3 		$163K Hold
41,320
– – ﹤0.01% 3002
2023
Q2 		$439K Buy
41,320
+6,520
+19% +$69.4K ﹤0.01% 2706
2023
Q1 		$290K Buy
34,800
+4,400
+14% +$39.7K ﹤0.01% 2787
2022
Q4 		$281K Buy
30,400
+2,900
+11% +$30.2K ﹤0.01% 2897
2022
Q3 		$353K Buy
27,500
+3,800
+16% +$60.6K ﹤0.01% 2797
2022
Q2 		$313K Buy
23,700
+3,900
+20% +$59.2K ﹤0.01% 2863
2022
Q1 		$417K Hold
19,800
– – ﹤0.01% 2753
2021
Q4 		$475K Buy
19,800
+1,200
+6% +$28.6K ﹤0.01% 2768
2021
Q3 		$473K Sell
18,600
-1,200
-6% -$33.5K ﹤0.01% 2776
2021
Q2 		$666K Buy
19,800
+1,700
+9% +$60.1K ﹤0.01% 2693
2021
Q1 		$703K Buy
18,100
+700
+4% +$39.9K ﹤0.01% 2542
2020
Q4 		$1.08M Sell
17,400
-3,300
-16% -$151K ﹤0.01% 2262
2020
Q3 		$693K Sell
20,700
-1,200
-5% -$34.3K ﹤0.01% 2352
2020
Q2 		$522K Buy
21,900
+4,600
+27% +$109K ﹤0.01% 2582
2020
Q1 		$396K Buy
+17,300
New +$427K ﹤0.01% 2471

Other funds holding STOK

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
LCM
Lynx1 Capital Management San Juan, Puerto Rico $866M AUM 231.68% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Toronto Dominion Bank
Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $86.4B AUM 59.51% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

AllianceBernstein's STOK Position: Q2 2026 in Review

AllianceBernstein increased its Stoke Therapeutics (STOK) stake by 49% in Q2 2026, buying an estimated $660K and bringing the position to 62,390 shares worth $2.03M. The position accounts for ﹤0.01% of the portfolio, ranked #2038.

AllianceBernstein first reported a position in STOK in Q1 2020 and has held it in 26 quarters since. 197 funds tracked by Wall St. Rank hold STOK as of Q2 2026.

  • AllianceBernstein held 62,390 shares of Stoke Therapeutics worth $2.03M as of Q2 2026.
  • AllianceBernstein bought 20,560 Stoke Therapeutics shares in Q2 2026, an estimated $660K.
  • Stoke Therapeutics made up ﹤0.01% of AllianceBernstein's portfolio in Q2 2026, its #2038 holding.
  • AllianceBernstein first reported a position in Stoke Therapeutics in Q1 2020 and has held it in 26 quarters since.
  • 197 funds tracked by Wall St. Rank held Stoke Therapeutics as of Q2 2026.

Based on AllianceBernstein's 13F filing for Q2 2026, filed 14 Aug 2026.